Management Team
Eric S. Perlman, M.D.
Chief Scientific Officer
 As Chief Scientific Officer, Dr. Perlman works with sponsors to develop and implement molecular imaging solutions for drug development clinical trials. He oversees all studies that include PET and other nuclear medicine imaging techniques. Dr. Perlman has more than 15 years clinical experience as a diagnostic radiologist and is board certified in Internal Medicine (1988) and Diagnostic Radiology (1992). Dr. Perlman completed medical imaging training as a Fellow in body imaging at Yale University School of Medicine (1993). He was awarded certification of special competency in Nuclear Medicine in 1993 and achieved certification by the American Society of Nuclear Cardiology in 1995.
Dr. Perlman has been involved with medical imaging in the clinical trials area since 1997. He was one of the first Radiologist readers for clinical trials work performed at RadPharm and he has been directly involved as a Radiologist reader/reviewer in over 80 clinical trials. In addition to performing imaging analysis, Dr. Perlman’s responsibilities on these and other projects include protocol review with imaging consultation and imaging charter and imaging manual development. He presents regularly at Investigator meetings as well as international industry meetings on the topic of molecular imaging in clinical trials. |
